Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Mynarek

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Pediatric Transplantation|November 25, 2011
Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with Hurler syndromeLorenz Grigull, Karl-Walter Sykora, Andreas Tenger, et al.
Journal of Neuro-Oncology|June 26, 2025
CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papillomaChristian Fiedler, Uwe R Kordes, Christian Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studiesKlaus Müller, Martin Mynarek, Isabella Zwiener, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica|April 12, 2021
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtypeCatena Kresbach, Mario M Dorostkar, Abigail K Suwala, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Neuro-Oncology|June 26, 2024
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategiesMarthe Sönksen, Denise Obrecht-Sturm, Pablo Hernáiz Driever, et al.
Acta Neuropathologica|November 4, 2019
Molecular characterization of histopathological ependymoma variantsJulia E Neumann, Michael Spohn, Denise Obrecht, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Pediatric Transplantation|November 25, 2011
Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with Hurler syndromeLorenz Grigull, Karl-Walter Sykora, Andreas Tenger, et al.
Journal of Neuro-Oncology|June 26, 2025
CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papillomaChristian Fiedler, Uwe R Kordes, Christian Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studiesKlaus Müller, Martin Mynarek, Isabella Zwiener, et al.
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica|April 12, 2021
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtypeCatena Kresbach, Mario M Dorostkar, Abigail K Suwala, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Neuro-Oncology|June 26, 2024
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategiesMarthe Sönksen, Denise Obrecht-Sturm, Pablo Hernáiz Driever, et al.
Acta Neuropathologica|November 4, 2019
Molecular characterization of histopathological ependymoma variantsJulia E Neumann, Michael Spohn, Denise Obrecht, et al.
Pageof 10